Sonoma Pharmaceuticals Inc (SNOA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SNOA Annual Balance Sheets →
From Sonoma Pharmaceuticals Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent5.34
Cash & Short-term Investments5.00
Accounts receivable3.18
Inventories3.79
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.96
Total Current Assets16.27
Equipment/Property/Plant Net0.29
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.55
Operating Lease Right Of Use Asset0.64
Total Assets18.11
Liabilities
Accounts Payable, Current AC2.19
Accounts Payable and Other Accrued Liabilities2.67
Short-term Debt DE10.14
Other Liabilities, Current0.16
Deferred Revenue, Current DE0.28
Total Current Liabilities5.45
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent6.07
Operating Lease Liability Current0.15
Operating Lease Liability Noncurrent0.51
Withholding Tax Payable5.47
Total Liabilities11.51
Stockholders' Equity
Additional Paid In Capital Common Stock210.91
Retained Earnings / Accumulated Deficit-201.31
Accumulated Other Comprehensive Income-3.01
Other Equity-3.01
Common Stockholder's Equity6.59
Total Stockholder's Equity6.59
Liabilities & Stockholder's Equity18.11
4 historic quarters locked

Sign in to unlock the full Sonoma Pharmaceuticals Inc balance sheet history.

About Sonoma Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-006024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.